Intriguingly, both CXCL13, demonstrated as a promising prognostic biomarker for IPF [51], and CCL19 were found amongst the top four proteins most elevated in IPF serum at baseline. This evidence concerns the gene CCL19 and idiopathic pulmonary fibrosis.